Medicare Enrolled
Dr. Alfred Kalman, M.D.
Hematology & Oncology · Coral Springs, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kalman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalman
Dr. Alfred Kalman is a hematology & oncology specialist in Coral Springs, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kalman performed 15,472 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kalman received a total of $40,051 from 80 pharmaceutical and/or device companies across 1276 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 23% volume in FL
$40,051 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 35455 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗15,472
Medicare services
Top 23% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 2,790 | $2 | $7 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,210 | $6 | $20 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $18 | $54 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,560 | $7 | $8 |
| Anti-nausea injection (ondansetron/Zofran) | 1,544 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,531 | $8 | $19 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,092 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
523 | $66 | $229 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
332 | $99 | $324 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
301 | $51 | $161 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
279 | $13 | $78 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
227 | $97 | $304 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
201 | $104 | $335 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
172 | $12 | $39 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
169 | $23 | $29 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
166 | $11 | $35 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
110 | $15 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
103 | $142 | $442 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
94 | $14 | $88 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
92 | $23 | $72 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
72 | $19 | $47 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
59 | $1 | $3 |
| New patient office visit, complex (60-74 min) | 54 | $165 | $237 |
| PSA test (prostate cancer screening) | 40 | $18 | $46 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $145 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.3% high complexity
63.8% medium
31.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,051
Total received (2018-2024)
Avg $5,722/year across 7 years
Top 17% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,276
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,186
2023
$2,766
2022
$6,283
2021
$3,498
2020
$4,318
2019
$5,317
2018
$15,683
Payments by company (2024)
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,627
Janssen Biotech, Inc.
$251
AstraZeneca Pharmaceuticals LP
$50
Bayer Healthcare Pharmaceuticals Inc.
$48
GENZYME CORPORATION
$48
Takeda Pharmaceuticals U.S.A., Inc.
$31
Adaptive Biotechnologies Corporation
$26
E.R. Squibb & Sons, L.L.C.
$25
Tolmar, Inc.
$21
Amneal Pharmaceuticals LLC
$21
JAZZ PHARMACEUTICALS INC.
$20
Gilead Sciences, Inc.
$16
Top 3 companies account for 88.2% of 2024 payments
All-time payments by company (2018-2024) ›
Pharmacyclics LLC, An AbbVie Company
$5,574
Exelixis Inc.
$3,878
AbbVie, Inc.
$3,558
Incyte Corporation
$3,542
Janssen Biotech, Inc.
$2,421
AstraZeneca Pharmaceuticals LP
$1,983
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,779
BeiGene USA, Inc.
$1,726
E.R. Squibb & Sons, L.L.C.
$1,510
PFIZER INC.
$1,429
Lilly USA, LLC
$897
Novartis Pharmaceuticals Corporation
$759
Amgen Inc.
$735
GENZYME CORPORATION
$696
Takeda Pharmaceuticals U.S.A., Inc.
$600
Genentech USA, Inc.
$599
BeiGene, Ltd.
$525
Eisai Inc.
$502
Merck Sharp & Dohme Corporation
$480
EISAI INC.
$460
Seagen Inc.
$424
Celgene Corporation
$367
Foundation Medicine, Inc.
$362
JAZZ PHARMACEUTICALS INC.
$325
Bayer HealthCare Pharmaceuticals Inc.
$274
ABBVIE INC.
$267
Rigel Pharmaceuticals, Inc.
$258
Astellas Pharma US Inc
$246
Gilead Sciences, Inc.
$192
Puma Biotechnology, Inc.
$188
Ipsen Biopharmaceuticals, Inc
$185
Seattle Genetics, Inc.
$180
Alexion Pharmaceuticals, Inc.
$176
TerSera Therapeutics LLC
$152
Deciphera Pharmaceuticals Inc.
$146
AbbVie Inc.
$140
GlaxoSmithKline, LLC.
$129
PUMA BIOTECHNOLOGY, INC.
$126
Bayer Healthcare Pharmaceuticals Inc.
$125
TOLMAR Pharmaceuticals, Inc.
$115
Adaptive Biotechnologies Corporation
$114
EMD Serono, Inc.
$111
Dova Pharmaceuticals
$111
Janssen Pharmaceuticals, Inc
$99
ARRAY BIOPHARMA INC
$95
Karyopharm Therapeutics Inc.
$94
MEDIVATION FIELD SOLUTIONS LLC
$89
Merck Sharp & Dohme LLC
$88
Clovis Oncology, Inc.
$78
Taiho Oncology, Inc.
$77
Verastem, Inc.
$76
Regeneron Healthcare Solutions, Inc.
$74
Teva Pharmaceuticals USA, Inc.
$73
SERVIER PHARMACEUTICALS LLC
$70
Sobi, Inc
$69
Mirati Therapeutics, Inc.
$64
Daiichi Sankyo Inc.
$58
Spectrum Pharmaceuticals Inc.
$51
Amneal Pharmaceuticals LLC
$43
SANOFI-AVENTIS U.S. LLC
$41
Sun Pharmaceutical Industries Inc.
$40
TESARO, Inc.
$39
Kyowa Kirin, Inc.
$35
Advanced Accelerator Applications
$31
Octapharma USA, Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
ImmunoGen, Inc.
$22
Sandoz Inc.
$21
Tolmar, Inc.
$21
Organon LLC
$21
Verity Pharmaceuticals Inc.
$20
Acceleron Pharma, Inc.
$18
Heron Therapeutics, Inc.
$18
Ethicon US, LLC
$17
Stemline Therapeutics Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Array BioPharma Inc.
$12
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Alecensa · Aliqopa · Avastin · BENDEKA · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · FARESTON · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAPLAS · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · WILATE · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · YONSA (abiraterone acetate) · ZARXIO · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
115
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
BROWARD HEALTH CORAL SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kalman is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kalman experienced with injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg?
Based on Medicare claims data, Dr. Kalman performed 2,790 injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kalman receive payments from pharmaceutical companies?
Yes. Dr. Kalman received a total of $40,051 from 80 companies across 1,276 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalman's costs compare to other hematology & oncology specialists in Coral Springs?
Dr. Kalman's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Coral Springs
Browse hematology & oncology specialists in Coral Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Pharmacyclics LLC, An AbbVie Company Payments to Doctors
See all physicians who received payments from Pharmacyclics LLC, An AbbVie Company.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology